- Home
- TARA vs JRVR Comparison
TARA vs JRVR Comparison
Compare TARA & JRVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TARA | JRVR |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.5M | 288.2M |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TARA | JRVR |
|---|---|---|
| Price | $5.11 | $6.12 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | ★ $21.67 | $7.33 |
| AVG Volume (30 Days) | ★ 673.0K | 254.9K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.65% |
| EPS Growth | 38.25 | ★ 125.82 |
| EPS | N/A | ★ 0.79 |
| Revenue | $2,948,000.00 | ★ $687,614,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.61 |
| P/E Ratio | ★ N/A | $7.75 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.77 | $3.86 |
| 52 Week High | $7.82 | $7.20 |
Technical Indicators
Market Signals| Indicator | TARA | JRVR |
|---|---|---|
| Relative Strength Index (RSI) | 42.79 | 41.71 |
| Support Level | $4.95 | $6.07 |
| Resistance Level | $5.39 | $6.14 |
| Average True Range (ATR) | 0.29 | 0.20 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 44.93 | 27.78 |
Price Performance
Historical ComparisonAbout TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About JRVR James River Group Holdings Ltd.
James River Group Holdings Inc is a holding company that owns and operates a group of specialty insurance companies focused on underwriting small and middle market casualty risks within the U.S. excess and surplus (E&S) lines market. The Company operates in two specialty property-casualty insurance segments: Excess and Surplus Lines and Specialty Admitted Insurance.